Literature DB >> 21562104

Isolation of Mycobacterium tuberculosis strains with a silent mutation in rpoB leading to potential misassignment of resistance category.

María Alonso1, Juan José Palacios, Marta Herranz, Ana Penedo, Angela Menéndez, Emilio Bouza, Darío García de Viedma.   

Abstract

Our study provides an alert regarding the transmission of rifampin-susceptible strains of Mycobacterium tuberculosis with a silent substitution in codon 514 of rpoB. Among 1,450 cases, we identified 12 isolates sharing this mutation and related restriction fragment length polymorphism (RFLP) types. The mutation impaired hybridization with the wild-type probes in three independent commercial assays, which could lead to misassignment of resistance.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21562104      PMCID： PMC3147855          DOI： 10.1128/JCM.00659-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Epidemiologic import of tuberculosis cases whose isolates have similar but not identical IS6110 restriction fragment length polymorphism patterns.

Authors:  M D Cave; Z H Yang; R Stefanova; N Fomukong; K Ijaz; J Bates; K D Eisenach
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

2.  Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.

Authors:  Marinus Barnard; Heidi Albert; Gerrit Coetzee; Richard O'Brien; Marlein E Bosman
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

3.  Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.

Authors:  V Kapur; L L Li; S Iordanescu; M R Hamrick; A Wanger; B N Kreiswirth; J M Musser
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

4.  Preferential deletion events in the direct repeat locus of Mycobacterium tuberculosis.

Authors:  Anita C Schürch; Kristin Kremer; Albert Kiers; Martin J Boeree; Roland J Siezen; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

5.  The IS6110 restriction fragment length polymorphism in particular multidrug-resistant Mycobacterium tuberculosis strains may evolve too fast for reliable use in outbreak investigation.

Authors:  A Alito; N Morcillo; S Scipioni; A Dolmann; M I Romano; A Cataldi; D van Soolingen
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  DNA fingerprint changes in tuberculosis: reinfection, evolution, or laboratory error?

Authors:  Judith R Glynn; Malcolm D Yates; Amelia C Crampin; Bagrey M Ngwira; Frank D Mwaungulu; Gillian F Black; Steven D Chaguluka; Donex T Mwafulirwa; Sian Floyd; Caroline Murphy; Francis A Drobniewski; Paul E M Fine
Journal:  J Infect Dis       Date:  2004-08-03       Impact factor: 5.226

Review 7.  A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.

Authors:  Maureen Morgan; Shriprakash Kalantri; Laura Flores; Madhukar Pai
Journal:  BMC Infect Dis       Date:  2005-07-28       Impact factor: 3.090

8.  Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family.

Authors:  Mina Ebrahimi-Rad; Pablo Bifani; Carlos Martin; Kristin Kremer; Sofia Samper; Jean Rauzier; Barry Kreiswirth; Jesus Blazquez; Marc Jouan; Dick van Soolingen; Brigitte Gicquel
Journal:  Emerg Infect Dis       Date:  2003-07       Impact factor: 6.883

9.  Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology.

Authors:  Karine Brudey; Jeffrey R Driscoll; Leen Rigouts; Wolfgang M Prodinger; Andrea Gori; Sahal A Al-Hajoj; Caroline Allix; Liselotte Aristimuño; Jyoti Arora; Viesturs Baumanis; Lothar Binder; Patricia Cafrune; Angel Cataldi; Soonfatt Cheong; Roland Diel; Christopher Ellermeier; Jason T Evans; Maryse Fauville-Dufaux; Séverine Ferdinand; Dario Garcia de Viedma; Carlo Garzelli; Lidia Gazzola; Harrison M Gomes; M Cristina Guttierez; Peter M Hawkey; Paul D van Helden; Gurujaj V Kadival; Barry N Kreiswirth; Kristin Kremer; Milan Kubin; Savita P Kulkarni; Benjamin Liens; Troels Lillebaek; Minh Ly Ho; Carlos Martin; Christian Martin; Igor Mokrousov; Olga Narvskaïa; Yun Fong Ngeow; Ludmilla Naumann; Stefan Niemann; Ida Parwati; Zeaur Rahim; Voahangy Rasolofo-Razanamparany; Tiana Rasolonavalona; M Lucia Rossetti; Sabine Rüsch-Gerdes; Anna Sajduda; Sofia Samper; Igor G Shemyakin; Urvashi B Singh; Akos Somoskovi; Robin A Skuce; Dick van Soolingen; Elisabeth M Streicher; Philip N Suffys; Enrico Tortoli; Tatjana Tracevska; Véronique Vincent; Tommie C Victor; Robin M Warren; Sook Fan Yap; Khadiza Zaman; Françoise Portaels; Nalin Rastogi; Christophe Sola
Journal:  BMC Microbiol       Date:  2006-03-06       Impact factor: 3.605

10.  Evolution and diversity of clonal bacteria: the paradigm of Mycobacterium tuberculosis.

Authors:  Tiago Dos Vultos; Olga Mestre; Jean Rauzier; Marcin Golec; Nalin Rastogi; Voahangy Rasolofo; Tone Tonjum; Christophe Sola; Ivan Matic; Brigitte Gicquel
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240
View more
  24 in total

1.  Silent mutation in rpoB detected from clinical samples with rifampin-susceptible Mycobacterium tuberculosis.

Authors:  Raquel Moure; Rogelio Martín; Fernando Alcaide
Journal:  J Clin Microbiol       Date:  2011-10       Impact factor: 5.948

2.  Discordance between Xpert MTB/RIF assay and Bactec MGIT 960 Culture System for detection of rifampin-resistant Mycobacterium tuberculosis isolates in a country with a low tuberculosis (TB) incidence.

Authors:  Eiman Mokaddas; Suhail Ahmad; Hanaa S Eldeen; Noura Al-Mutairi
Journal:  J Clin Microbiol       Date:  2015-01-21       Impact factor: 5.948

3.  DNA sequencing for confirmation of rifampin resistance detected by Cepheid Xpert MTB/RIF assay.

Authors:  Allison J McAlister; Jeffrey Driscoll; Beverly Metchock
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

Review 4.  Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance.

Authors:  Claudio U Köser; Silke Feuerriegel; David K Summers; John A C Archer; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

5.  Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens.

Authors:  S-Y Grace Lin; Timothy C Rodwell; Thomas C Victor; Errin C Rider; Lucy Pham; Antonino Catanzaro; Edward P Desmond
Journal:  J Clin Microbiol       Date:  2013-11-27       Impact factor: 5.948

6.  Simplified microarray system for simultaneously detecting rifampin, isoniazid, ethambutol, and streptomycin resistance markers in Mycobacterium tuberculosis.

Authors:  Yvonne Linger; Alexander Kukhtin; Julia Golova; Alexander Perov; Amine Lambarqui; Lexi Bryant; George B Rudy; Kim Dionne; Stefanie L Fisher; Nicole Parrish; Darrell P Chandler
Journal:  J Clin Microbiol       Date:  2014-04-09       Impact factor: 5.948

Review 7.  Evaluation of the Cepheid Xpert MTB/RIF assay.

Authors:  Thomas M Shinnick; Angela M Starks; Heather L Alexander; Kenneth G Castro
Journal:  Expert Rev Mol Diagn       Date:  2014-11-06       Impact factor: 5.225

8.  Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use.

Authors:  Soumitesh Chakravorty; Sandy S Roh; Jennifer Glass; Laura E Smith; Ann Marie Simmons; Kevin Lund; Sergey Lokhov; Xin Liu; Peng Xu; Guolong Zhang; Laura E Via; Qingyu Shen; Xianglin Ruan; Xing Yuan; Hong Zhu Zhu; Ekaterina Viazovkina; Shubhada Shenai; Mazhgan Rowneki; Jong Seok Lee; Clifton E Barry; Qian Gao; David Persing; Robert Kwiatkawoski; Martin Jones; Alexander Gall; David Alland
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

9.  Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences.

Authors:  Francesc Coll; Ruth McNerney; Mark D Preston; José Afonso Guerra-Assunção; Andrew Warry; Grant Hill-Cawthorne; Kim Mallard; Mridul Nair; Anabela Miranda; Adriana Alves; João Perdigão; Miguel Viveiros; Isabel Portugal; Zahra Hasan; Rumina Hasan; Judith R Glynn; Nigel Martin; Arnab Pain; Taane G Clark
Journal:  Genome Med       Date:  2015-05-27       Impact factor: 11.117

10.  Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results.

Authors:  Oksana Ocheretina; Vincent E Escuyer; Marie-Marcelle Mabou; Gertrude Royal-Mardi; Sean Collins; Stalz C Vilbrun; Jean W Pape; Daniel W Fitzgerald
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.